［1］ Dvorak HF. Tumors：wounds that do not heal. Similarities between tumor stroma generation and wound healing ［J］. N Engl J Med，1986，315（26）：1650-1659.［2］ Namba H. Glioma treatment strategies using mesenchymal stem cells ［J］. Brain Nerve，2010，62（10）：1075-1082.［3］ Fritz V，Jorgensen C. Mesenchymal stem cells：an emerging tool for cancer targeting and therapy ［J］. Curr Stem Cell Res Ther，2008，3（1）：32-42.［4］ Sutton A，Friand V，Brule-Donneger，et al. Stromal cell-derived factor-1/chemokine（C-X-C motif）ligand 12 stimulates human hepatoma cell growth，migration，and invasion ［J］. Mol Cancer Res，2007，5（1）：21-33.［5］ Kryczek I，Wei S，Keller E，et al. Stroma-derived factor （SDF-1/CXCL12） and human tumor pathogenesis ［J］. Am J Physiol Cell Physiol，2007，292（3）：C987-995.［6］ Balkwill F. Cancer and the chemokine network ［J］. Nat Rev Cancer，2004，4（7）：540-550.［7］ Xu F，Shi J，Yu B，et al. Chemokines mediate mesenchymal stem cell migration toward gliomas in vitro ［J］. Oncol Rep，2010，23（6）：1561-1567.［8］ Tabatabai G，Frank B，Mohle R，et al. Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12 ［J］. Brain，2006，129：2426-2435.［9］ Tabatabai G，Bahr O，Mohle R，et al. Lessons from the bone marrow：how malignant glioma cells attract adult haematopoietic progenitor cells ［J］. Brain，2005，128：2200-2211.［10］ Strieter RM. Masters of angiogenesis ［J］. Nat Med，2005，11（9）：925-927.［11］ Cao Y，Luetkens T，Kobold S，et al. The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients ［J］. Exp Hematol，2010，38（10）：860-867. ［12］ Brooke G，Tong H，Levesque JP，et al. Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta ［J］. Stem Cells Dev，2008，17（5）：929-940.［13］ Honeth G，Staflin K，Kalliomaki S，et al. Chemokine-directed migration of tumor-inhibitory neural progenitor cells towards an intracranially growing glioma ［J］. Exp Cell Res，2006，312（8）：1265-1276.［14］ Aboody KS，Brown A，Rainov NG，et al. Neural stem cells display extensive tropism for pathology in adult brain：evidence from intracranial gliomas ［J］. Proc Natl Acad Sci U S A，2000，97（23）：12846-12851.［15］ Dwyer RM，Potter-Beirne SM，Harrington KA，et al. Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells ［J］. Clin Cancer Res，2007，13（17）：5020-5027.［16］ Lien CY，Chih-Yuan HK，Lee OK，et al. Restoration of bone mass and strength in glucocorticoid-treated mice by systemic transplantation of CXCR4 and cbfa-1 co-expressing mesenchymal stem cells ［J］. J Bone Miner Res，2009，24（5）：837-848.［17］ Rosova I，Dao M，Capoccia B，et al. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells ［J］. Stem Cells，2008，26（8）：2173-2182.［18］ Liu H，Liu S，Li Y，et al. The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury ［J］. PLoS One，2012，7（4）：e34608.［19］ Tang YL，Zhu W，Cheng M，et al. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression ［J］. Circ Res，2009，104（10）：1209-1216.［20］ Kim SM，Oh JH，Park SA，et al. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy ［J］. Stem Cells，2010，28（12）：2217-2228.［21］ Klopp AH，Spaeth EL，Dembinski JL，et al. Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment ［J］. Cancer Res，2007，67（24）：11687-11695.
